Literature DB >> 16965837

Vasoactive intestinal peptide enhances wound healing and proliferation of human bronchial epithelial cells.

Cha-Xiang Guan1, Min Zhang, Xiao-Qun Qin, Yan-Ru Cui, Zi-Qiang Luo, Hong-Bo Bai, Xiang Fang.   

Abstract

In the present study, we investigated the effects of vasoactive intestinal peptide (VIP) on wound healing of bronchial epithelium. Wound healing of the mechanical damaged human bronchial epithelial cells (HBEC) was observed in the absence or presence of VIP. Effects of VIP on chemotactic migration, cell proliferation of HBEC were also tested. HBEC chemotaxis was assessed by the blind well chamber technique, the cell cycle was determined by flow cytometry, and cell proliferation was determined by measuring the expression of proliferating cell nuclear antigen Ki67. Effects of VIP on epithelial E-cadherins protein and mRNA were also measured by immunohistochemistry and RT-PCR. The results showed that VIP accelerated the recovery of wound area of HBEC. VIP increased the migration and proliferation of HBEC, and these effects were blocked by a VPAC1 receptor antagonist. VIP also increased the expression of E-cadherin mRNA and protein in HBEC, suggesting that protective effects of VIP on wound healing may be related to its ability to increase the expression of E-cadherin. In conclusion, VIP has protective effects against human bronchial epithelial cell damage, and the beneficial effects of VIP might be mediated, at least in part, by VPAC1, and associated with increased expression of E-cadherin.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16965837     DOI: 10.1016/j.peptides.2006.08.004

Source DB:  PubMed          Journal:  Peptides        ISSN: 0196-9781            Impact factor:   3.750


  6 in total

1.  Vasoactive intestinal peptide suppresses macrophage-mediated inflammation by downregulating interleukin-17A expression via PKA- and PKC-dependent pathways.

Authors:  Wen-Zhuo Ran; Liang Dong; Chun-Yan Tang; Yong Zhou; Guo-Ying Sun; Tian Liu; Yong-Ping Liu; Cha-Xiang Guan
Journal:  Int J Exp Pathol       Date:  2015-05-05       Impact factor: 1.925

2.  Spatio-temporal localization of vasoactive intestinal peptide and neutral endopeptidase in allergic murine lungs.

Authors:  Amali E Samarasinghe; Scott A Hoselton; Jane M Schuh
Journal:  Regul Pept       Date:  2010-06-08

3.  The absence of the VPAC(2) receptor does not protect mice from Aspergillus induced allergic asthma.

Authors:  A E Samarasinghe; S A Hoselton; J M Schuh
Journal:  Peptides       Date:  2010-03-11       Impact factor: 3.750

Review 4.  Neuroimmune Pathophysiology in Asthma.

Authors:  Gandhi F Pavón-Romero; Nancy Haydée Serrano-Pérez; Lizbeth García-Sánchez; Fernando Ramírez-Jiménez; Luis M Terán
Journal:  Front Cell Dev Biol       Date:  2021-05-13

Review 5.  Prospect of vasoactive intestinal peptide therapy for COPD/PAH and asthma: a review.

Authors:  Dongmei Wu; Dongwon Lee; Yong Kiel Sung
Journal:  Respir Res       Date:  2011-04-11

6.  Intratracheal Administration of Mesenchymal Stem Cells Modulates Tachykinin System, Suppresses Airway Remodeling and Reduces Airway Hyperresponsiveness in an Animal Model.

Authors:  Konrad Urbanek; Antonella De Angelis; Giuseppe Spaziano; Elena Piegari; Maria Matteis; Donato Cappetta; Grazia Esposito; Rosa Russo; Gioia Tartaglione; Raffaele De Palma; Francesco Rossi; Bruno D'Agostino
Journal:  PLoS One       Date:  2016-07-19       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.